Endocrine and metabolic diseases. Adrenal diseases.
D000236:Adenoma / Q000601:surgery; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000307:Adrenal Gland Diseases; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000309:Adrenal Insufficiency; D000313:Adrenal Medulla; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D003480:Cushing Syndrome / Q000188:drug therapy; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D006965:Hyperplasia / Q000151:congenital / Q000188:drug therapy; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D008939:Mitotane; D008797:Metyrapone